Clinical Highlights from the 2020 Midyear: Therapeutic Debates 2020: Lytic Critics: Alteplase vs Tenecteplase for Acute Ischemic Stroke

In this debate style presentation from the 2020 Midyear Clinical Meeting, our content matter experts will review the key literature on both Alteplase and Tenecteplase and their roles in the management of acute ischemic stroke and how their pharmacokinetic and structural differences play a role in therapy. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.